These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Ifosfamide in the treatment of pediatric malignancies. Voûte PA, van den Berg H, Behrendt H, Michiels E, de Kraker J. Semin Oncol; 1996 Jun; 23(3 Suppl 7):8-11. PubMed ID: 8711502 [Abstract] [Full Text] [Related]
8. L-asparaginase in the treatment of neoplastic diseases in children. Jaffe N, Traggis D, Das L, Moloney WC, Hann HW, Kim BS, Nair R. Cancer Res; 1971 Jul; 31(7):942-9. PubMed ID: 4327086 [No Abstract] [Full Text] [Related]
9. [The treatment of some infantile malignant neoplasms with Vinca rosea alkaloids]. Nigro N, Madon E. Cancro; 1968 Jul; 21():Suppl 6:119+. PubMed ID: 4313386 [No Abstract] [Full Text] [Related]
10. The evolution of chemotherapeutic agents for the treatment of pediatric musculoskeletal malignancies. Velez-Yanguas MC, Warrier RP. Orthop Clin North Am; 1996 Jul; 27(3):545-9. PubMed ID: 8649735 [Abstract] [Full Text] [Related]
11. A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. Antman K, Crowley J, Balcerzak SP, Kempf RA, Weiss RB, Clamon GH, Baker LH. Cancer; 1998 Apr 01; 82(7):1288-95. PubMed ID: 9529020 [Abstract] [Full Text] [Related]
12. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study. Blaney SM, Needle MN, Gillespie A, Sato JK, Reaman GH, Berg SL, Adamson PC, Krailo MD, Bleyer WA, Poplack DG, Balis FM. Clin Cancer Res; 1998 Feb 01; 4(2):357-60. PubMed ID: 9516923 [Abstract] [Full Text] [Related]
13. [Cytostatic treatment as supplement in osteosarcoma and Ewing's sarcoma. Preliminary communication (author's transl)]. Krizan Z, Makai F, Krizan I, Blasková L, Látal J, Majeský B. Acta Chir Orthop Traumatol Cech; 1979 Feb 01; 46(1):26-8. PubMed ID: 88152 [No Abstract] [Full Text] [Related]
14. [Treatment of malignant tumors in infants with antineoplastic agents]. Taguchi N. Naika; 1968 Sep 01; 22(3):634-9. PubMed ID: 4303515 [No Abstract] [Full Text] [Related]
15. [New perspectives for an adjuvant chemotherapy in solid tumors]. Schmidt CG, Seeber S. Dtsch Med Wochenschr; 1975 Nov 07; 100(45):2342-8. PubMed ID: 171129 [No Abstract] [Full Text] [Related]
16. [Current problems of solid tumors in childhood]. Plüss HJ, Sartorius J, Wagner HP, Wyss M. Schweiz Med Wochenschr; 1974 May 04; 104(18):634-41. PubMed ID: 4363542 [No Abstract] [Full Text] [Related]
17. Advances in the management of musculoskeletal tumors in adolescents. Dyment PG. Cleve Clin Q; 1975 May 04; 42(4):303-8. PubMed ID: 765005 [No Abstract] [Full Text] [Related]
18. [Neoadjuvant chemotherapy of sarcoma. The experiences of the German Society for Pediatric Oncology studies on osteosarcoma, Ewing's sarcoma and rhabdomyosarcoma]. Winkler K, Jürgens H, Treuner J. Dtsch Med Wochenschr; 1987 Sep 04; 112(36):1385-90. PubMed ID: 3304927 [No Abstract] [Full Text] [Related]
20. Consumptive coagulopathy. A complication of therapy of solid tumors in childhood. Sills RH, Stockman JA, Miller ML, Stuart MJ. Am J Dis Child; 1978 Sep 04; 132(9):870-2. PubMed ID: 685903 [Abstract] [Full Text] [Related] Page: [Next] [New Search]